Michael Secora - Chief Financial Officer at Recursion Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
RXRX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Michael Secora - trading volume in the past year for Recursion Pharmaceuticals, Inc.

Holdings reported by Michael Secora for Recursion Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Class A Common Stock 1.49M $9.19M $6.18 Nov 15, 2024 Direct
Stock Option (Right to Buy) 348K Nov 15, 2024 Direct Class A Common Stock 0

Transactions reported by Michael Secora for Recursion Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.